Ayse Saatci Yasar

Ayse Saatci Yasar

Auto-generated profile, based on publicly available information

Ayse Saatci Yasar

Department of Cardiology, University of Health Sciences, Gülhane Training and Research Hospital, 06010 Ankara, Türkiye

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2014 in Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
MBMehmet Bilge
Mehmet Bilge
AYAyse Saatci Yasar
Ayse Saatci Yasar
SASina Ali
Sina Ali
RARecai Alemdar
Recai Alemdar
Anadolu Kardiyoloji Dergisi, Anadolu Kardiyol Derg, The Anatolian Journal of Cardiology, Anatol J Cardiol, Cardiology, Cardiovascular Medicine, Surgery, Pediatric Cardiology, Angiology

18 August 2013 in Journal of Interventional Cardiology
Verified
Journal Article
Closed access
PDF file
AYAyse S. Yasar
Ayse S. Yasar
APAlexander C. Perino
Alexander C. Perino
PDPhilip B. Dattilo
Philip B. Dattilo
ICIvan P. Casserly
Ivan P. Casserly
JCJohn D. Carroll
John D. Carroll
JMJohn C. Messenger
John C. Messenger

1 July 2022 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
HTHatice Tolunay
Hatice Tolunay
EYErkan Yildirim Yildirim
Erkan Yildirim Yildirim
YGYalcin Gokoglan
Yalcin Gokoglan
BBBaris Bugan
Baris Bugan
AYAyse Saatci Yasar
Ayse Saatci Yasar
CBCem Barcin
Cem Barcin
Menopause,penile-vaginal intercourse,heart rate variability,autonomic ner- vous system

1 June 2021 in Gulhane Medical Journal
Verified
Journal Article
Closed access
HTHatice Tolunay
Hatice Tolunay
SGSuat Görmel
Suat Görmel
SASerkan Asil
Serkan Asil
SYSalim Yaşar
Salim Yaşar
EYErkan Yildirim Yildirim
Erkan Yildirim Yildirim
CBCem Barçın
Cem Barçın

1 July 2021 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
SGSuat Gormel
Suat Gormel
SYSalim Yasar
Salim Yasar
SASerkan Asil
Serkan Asil
EYErkan Yildirim Yildirim
Erkan Yildirim Yildirim
SFSerdar Firtina
Serdar Firtina
ATAnkara- Turkey
Ankara- Turkey
Objective: The management of severe functional mitral regurgitation (FMR) in patients with heart failure (HF) and low ejection fraction is controversial, but percutaneous transcatheter procedures are promising. In this retrospective analysis, we aimed to assess the efficacy of the Carillon Mitral Contour System in patients with "inoperable" severe FMR. Methods: Seventy three patients (mean age 66.89, range 31-90 years) with congestive heart failure (CHF), severe FMR, and reduced ejection fraction (<35%) who underwent Carillon device implantation were examined. The study group consisted of patients with successfully implanted devices whereas the control group comprised patients in whom the device could not be deployed. The primary endpoint was combined allcause mortality and first hospitalization for HF (whichever came first). Results: The median (Q1, Q3) follow-up was 31 (11-49) months. The device was deployed successfully in 50 patients (implant group) and not in 23 patients (non-implant group). Both the primary endpoint and all-cause mortality were lower in the "implant" group, but the differences were not significant. The median to primary endpoint was 21 [95% confidence interval (CI) 8.8-33.2] and six (95% CI 0.1-11.9) months for the implant group and the non-implant group, respectively (p=0.078). Conclusion: Carillon Mitral Contour System implantation is a safe procedure and results in the reduction of all-cause mortality and combined endpoint of mortality and hospitalizations for HF in inoperable patients with severe FMR and low ejection fraction, although the difference did not meet the significance level.

20 March 2025 in Research Square
Verified
Preprint
Open access
PDF file
EMEnder Murat
Ender Murat
MKMehmet Sadık Karpat
Mehmet Sadık Karpat
YÖYusuf Öztürk
Yusuf Öztürk
HTHatice Taşkan
Hatice Taşkan
OKOzan Köksal
Ozan Köksal
CBCem Barçın
Cem Barçın
Aim This study aimed to evaluate the relationship between endothelial activation and stress index (EASIX) score and 24-hour ambulatory blood pressure monitoring (24-h ABPM) parameters in patients with hypertension (HT). Methods This was a retrospective study. The EASIX score was calculated using the following formula [lactate dehydrogenase (LDH), U/L] × [creatinine (CRE), mg/dL] / [platelet (PLT), x109/L]. The EASIX variable was used for statistical analyses with Log2 (EASIX) transformation. Results The study included 192 patients aged between 18 and 70 years with a diagnosis of HT, with 40% (n = 77) of the patients being male. When the patients were grouped according to whether their blood pressure (BP) was within the target range, a statistically significant difference was found between the groups in terms of the EASIX score (p < 0.05). The threshold value for the EASIX score was found to be 0.48 because on receiver operating characteristic (ROC) analysis in the group with and without BP target because of 24-h ABPM. The area under the curve (AUC) and confidence interval (CI) values provided evidence of the usability of the threshold value [AUC = 0.755 (%95 CI = 0.685–0.825)]. Conclusion The EASIX score is a predictor that can be easily calculated in clinical practice using three blood parameters (LDH, CRE, and PLT). The EASIX score was found to have good predictive power in HT patients without comorbidities who were divided into groups of patients with and without target BP after 24-h ABPM.